Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 24Gastrointestinal 16Genitourinary 13Other 8Head & Neck 7Thoracic 5Other hematologic neoplasm 5Lymphoid 5Plasma cell 4Gynecologic 4CNS 4Tumor-Agnostic 2Sarcoma 2Other solid neoplasm 2Endocrine 2Other neoplasm 1Myeloid 1Dermatologic 1

Conditions

Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Limb-girdle muscular dystrophy, type 2C 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Resistance Training × Endocrine × Clear all
NCT00786019 2023-07-12

InsITE

University of Colorado, Denver

Phase NA Completed
47 enrolled 22 charts
Endocrine

Limb-girdle muscular dystrophy, type 2C, Diabetes Mellitus, Diabetes Mellitus, Type 2, Motor Activity, Multiple Endocrine Neoplasia Type 1

NCT04284605 2021-10-27

Effects Exercise Training in Patients With Pituitary Adenoma

Hacettepe University

Phase NA Completed
10 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡